Mr. Gregg Battersby of Aphria reports

APHRIA SIGNS WHOLESALE SUPPLY AGREEMENT WITH EMBLEM CANNABIS CORPORATION

Aphria Inc. has entered into a wholesale supply agreement with Emblem Cannabis Corp., wholly owned subsidiary of Emblem Corp. and a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, to supply 175,000 kilograms of high-quality cannabis over a five-year period starting May, 2019, with a total of 25,000 kg deliverable for the balance of the first year. Under the terms of the agreement, Aphria will receive a non-refundable deposit of $22.8-million, which comprises $12.8-million in cash and 6,952,169 of common shares of Emblem. The Emblem common shares issued to Aphria are subject to a contractual lockup and standstill arrangement, with five equal releases over the term of the agreement, subject to certain customary exceptions.

  
                          Year   Total quantity (kg; in dried flower equivalent)

May 1, 2019, to April 30, 2020                                           25,000
May 1, 2020, to April 30, 2021                                           30,000
May 1, 2021, to April 30, 2022                                           35,000
May 1, 2022, to April 30, 2023                                           40,000
May 1, 2023, to April 30, 2024                                           45,000


  
  

"Aphria's total annualized production capabilities are about to reach 255,000 kg in early 2019, which means we are not only well positioned to meet all of our supply commitments across Canada and anticipated international demand, but also have the capacity to support the projected demand through our partners," said Gregg Battersby, vice-president of commercial strategy at Aphria. "We are pleased to be able to support Emblem with a supply of high-quality cannabis grown in our Leamington greenhouses, while securing healthy revenue and margins for Aphria over the next five years."

Over the term of the agreement, Aphria will provide Emblem with a supply of high-quality dried flower and cannabis extract expertly grown in the company's greenhouse facilities in Leamington, Ont.

The company has a good thing growing.

About Aphria Inc.

Aphria is a leading global cannabis company driven by an unrelenting commitment to its people, product quality and innovation. Headquartered in Leamington, Ont. -- the greenhouse capital of Canada -- Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company's portfolio of brands is grounded in expertly researched consumer insights designed to meet the needs of every consumer segment.

We seek Safe Harbor.